You are here

Basic Neuroscience Related Content


Susan L. Andersen, PhD

Susan L. Andersen, PhD, is director of the Laboratory of Developmental Neuropharmacology at McLean Hospital and an associate professor of psychiatry at Harvard Medical School. She is interested in understanding how the brain typically matures between childhood, adolescence, and adulthood. Her...

Ross J. Baldessarini, MD

A career investigator of the NIMH from 1970 to 2001, Ross J. Baldessarini, MD, is an internationally known research psychopharmacologist with many contributions to the actions of antipsychotic and mood-altering medicines and has trained over 160 laboratory and clinical investigators. He joined...

Darrick T. Balu, PhD

Darrick T. Balu, PhD, grew up in New York City where he earned his undergraduate and Master’s degrees. After receiving his PhD from the University of Pennsylvania, he was awarded the Division 28: Psychopharmacology and Substance Abuse Outstanding Dissertation Award from the American...

Francine M. Benes, MD, PhD

In 1967, Dr. Benes received her bachelor's degree from St. John's University in New York and in 1972, completed a PhD in Cell Biology at Yale School of Medicine. Between 1972 and 1975, she received post-doctoral training at the City of Hope National Medical Center in California where she used single...

Sabina Berretta, MD

Sabina Berretta, MD, began her research training under the mentorship of Dr. V. Perciavalle at University of Catania, Italy. In 1990, she joined the laboratory directed by Dr. A. M. Graybiel in the Department of Brain and Cognitive Sciences at MIT, working neural circuitry linking the motor cortex...

Vadim Bolshakov, PhD

Dr. Bolshakov received his PhD from the Russian Academy of Sciences in St. Petersburg and performed his post-doctoral studies at Columbia University under the mentorship of Dr. Steven Siegelbaum. He joined McLean Hospital in 1999 as an assistant professor and was promoted to full professor at...

Oeystein R. Brekk, PhD

Oeystein R. Brekk, PhD, is currently working as a post-doctoral research fellow at McLean Hospital in the lab of Dr. Hallett. His research interests include cellular lipid and protein degradation systems—and their malfunction—in relation to Parkinson’s disease and other...

S. Barak Caine, PhD

S. Barak Caine, PhD, began his career as a research technician in the laboratory of Dr. Andrew Winokur at the University of Pennsylvania, before receiving pre-doctoral training in the laboratories of Dr. Mark Geyer at the University of California, and Dr. George Koob at The Scripps Research...

Bill Carlezon, PhD

Bill Carlezon, PhD, has received several awards for his research, including an Independent Investigator Award from the National Alliance for Research on Schizophrenia and Depression (NARSAD), the Presidential Early Career Award for Scientists and Engineers (PECASE) from George W. Bush, and the Jacob...

Franca Centorrino, MD

Franca Centorrino, MD, oversees a multidisciplinary team of clinicians treating outpatients with schizophrenia or bipolar disorder. Her research activities focus on the use of psychotropic medications for the treatment of schizophrenia and bipolar disorder and the management of side effects...

Young Cha, PhD

Young Cha, PhD, received his PhD in stem cell biology from CHA University in Korea. During his PhD studies, his scientific interest was to identify novel factors which are involved in the maintenance of self-renewality and pluripotency of embryonic stem cells. He joined the Molecular Neurobiology...

Elena H. Chartoff, PhD

Elena H. Chartoff, PhD, is an assistant professor of psychiatry at Harvard Medical School and director of the Neurobiology of Motivated Behavior Laboratory at McLean Hospital. She is interested in the neurobiological mechanisms that connect depression and anxiety with drug addiction. The work in her...

Yong Kee Choi, PhD

Yong Kee Choi, PhD, has extensive experiences in studying neuropsychiatric disorders such as schizophrenia, ADHD, and depression with the goal of creation of novel medications. Dr. Choi is currently focusing on developing advanced medications for childhood onset schizophrenia and major depressive...

Bruce M. Cohen, MD, PhD

Dr. Cohen leads a multidisciplinary research program on the causes of psychiatric disorders, with the goal of developing new, more effective, and better tolerated treatments. He and his colleagues employ pharmacologic, brain imaging, epidemiologic, genomic, and cell model approaches to study...

Joseph T. Coyle, MD

Joseph T. Coyle, MD, is the Eben S. Draper Chair of Psychiatry and Neuroscience at Harvard Medical School and was chairman of the Consolidated Department of Psychiatry at Harvard 1991-2001. A graduate of the College of the Holy Cross, he received his MD from Johns Hopkins. He completed an internship...

Miles Cunningham, MD, PhD

Miles G. Cunningham earned a PhD in 1993 from Massachusetts Institute of Technology, specializing in “Transplantation Strategies for the Analysis of Brain Development and Repair”. He earned an MD in 1995 from Harvard Medical School, with a special interest in neuropsychiatry and...

Nikolaos P. Daskalakis, MD, PhD

Nikolaos P. Daskalakis, MD, PhD, is an associate neuroscientist at McLean Hospital, a member of the faculty of psychiatry at Harvard Medical School and a BBRF-NARSAD young investigator. He received his MD from University of Athens, his PhD in neuropsychopharmacology from Leiden University, and...

Debkanya Datta, PhD

Debkanya Datta, PhD, focuses her research on the study of brain disorders using a stem cell-based approach. Her work involves development of human cellular models of neuropsychiatric disorders, using the Nobel Prize winning induced pluripotent stem cell (iPSC) technology to identify molecular and...

Rajeev I. Desai, PhD

Rajeev I. Desai, PhD, is an assistant professor of psychiatry at Harvard Medical School. He received his PhD from University of Birmingham, UK, before completing post-doctoral training at the National Institute on Drug Abuse. Dr. Desai joined the Preclinical Pharmacology Program (directed by Dr....

Fei Du, PhD

Fei Du, PhD has substantial background in high/ultra-high field MRS technical development and neuroscience application. In particular, he has applied EEG, fMRI and in vivo MRS to assess brain activity, cerebral metabolism of energy, and neurotransmitter Glu-Gln cycling.

Dr. Du's...

Pages